The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management
Over the past decades, accumulating evidence has demonstrated a pivotal role of cholecystokinin type 2 receptor (CCK2R) in pain modulation. The established role of CCK2R activation in directly facilitating nociception has led to the development of several CCK2R antagonists, which have been shown to...
Guardado en:
Autores principales: | Amandine Bernard, Aurore Danigo, Sylvie Bourthoumieu, Mohamad Mroué, Alexis Desmoulière, Franck Sturtz, Amandine Rovini, Claire Demiot |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f33ce5bb1927427ab60341e936ffe901 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Update on Preclinical Development and Clinical Translation of Cholecystokinin-2 Receptor Targeting Radiopharmaceuticals
por: Elisabeth von Guggenberg, et al.
Publicado: (2021) -
Ancient role of sulfakinin/cholecystokinin-type signalling in inhibitory regulation of feeding processes revealed in an echinoderm
por: Ana B Tinoco, et al.
Publicado: (2021) -
The entorhinal cortex modulates trace fear memory formation and neuroplasticity in the mouse lateral amygdala via cholecystokinin
por: Hemin Feng, et al.
Publicado: (2021) -
Anti-Hyperalgesic Properties of Menthol and Pulegone
por: Louis Hilfiger, et al.
Publicado: (2021) -
Habitat utilization of two muroid species in relation to population outbreaks in southern temperate forests of Chile
por: GONZALEZ,LUZ A, et al.
Publicado: (2000)